Peterson Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$688K Sell
748
-117
-14% -$119K 0.09% 51
2025
Q4
$930K Buy
865
+21
+2% +$20.1K 0.12% 46
2025
Q3
$712K Buy
844
+5
+0.6% +$3.72K 0.11% 53
2025
Q2
$654K Buy
839
+35
+4% +$27.2K 0.11% 55
2025
Q1
$582K Buy
804
+1
+0.1% +$832 0.11% 52
2024
Q4
$628K Buy
803
+87
+12% +$72K 0.11% 49
2024
Q3
$634K Buy
716
+56
+8% +$50.3K 0.12% 44
2024
Q2
$598K Buy
660
+10
+2% +$8K 0.13% 44
2024
Q1
$506K Sell
650
-26
-4% -$18.5K 0.11% 45
2023
Q4
$394K Buy
676
+25
+4% +$14.6K 0.09% 47
2023
Q3
$350K Sell
651
-11
-2% -$5.67K 0.09% 47
2023
Q2
$305K Hold
662
0.08% 51
2023
Q1
$227K Hold
662
0.06% 59
2022
Q4
$242K Hold
662
0.07% 55
2022
Q3
$214K Buy
662
+11
+2% +$3.48K 0.07% 56
2022
Q2
$211K Buy
+651
New +$195K 0.07% 54

Other funds holding LLY

Peterson Wealth Advisors's LLY Position: Q1 2026 in Review

Peterson Wealth Advisors reduced its Eli Lilly (LLY) stake by 14% in Q1 2026, selling an estimated $119K and leaving 748 shares worth $688K. The position accounts for 0.09% of the portfolio, ranked #51.

Peterson Wealth Advisors first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. The position peaked at $930K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Peterson Wealth Advisors held 748 shares of Eli Lilly worth $688K as of Q1 2026.
  • Peterson Wealth Advisors sold 117 Eli Lilly shares in Q1 2026, an estimated $119K.
  • Eli Lilly made up 0.09% of Peterson Wealth Advisors's portfolio in Q1 2026, its #51 holding.
  • Peterson Wealth Advisors first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
  • Peterson Wealth Advisors's Eli Lilly position peaked at $930K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Peterson Wealth Advisors's 13F filing for Q1 2026, filed 9 Apr 2026.